Cancer Pain

Investigational drug study evaluating the efficacy, safety and tolerability of study drug for cancer pain.

Eligible Participants:

18 years old or older
Participants who experience less than four episodes of breakthrough pain a day
Participant’s pain associated with cancer treatment.
Patients must currently be on a stable ongoing opioid therapy to control cancer-related pain

* study-related lab work, office visits and study drug available at no charge

* compensation for time and travel is available

Contact PainPathways for more information on this research trial at 336.714.8389

For more information about other current government research trials, visit www.clinicaltrials.gov. A service of the U.S. National Institutes of Health